The FDA has added at least three additional items to its growing roster of heartburn drug recalls.

Experts at Massachusetts General Hospital have successfully performed five CV transplants using Donation after Circulatory Death donor hearts—the largest number of adult DCD heart transplants ever completed in the U.S.

An analysis of 12 recent randomized clinical trials suggests a majority of patients with ischemic heart disease or a history of MI are eligible for new secondary prevention therapies—a finding that, if acted upon, could change a paradigm that’s been in place for decades.

U.K.-based drug giant AstraZeneca announced Jan. 13 it would be halting its Phase III trial of Epanova, a medication comprised of omega-3 carboxylic acids, early due to disappointing data.

The future of diabetes diagnosis and management could lie in a “smart” LED contact lens, a study published in Nature Reviews Materials suggests.

A group of scientists from the University of Alabama at Birmingham have derived predictive equations to identify adults at a high risk of having nocturnal hypertension or nondipping systolic blood pressure—both hard-to-catch conditions that can raise a person’s risk for CVD.

Taking a minimalist approach to transcatheter aortic valve implantation, which involves using conscious sedation in lieu of general anesthesia, could result in greater procedural efficiency and a comparable quality of life for patients.

Researchers studying ancient Inuit remains from Greenland have found that three in four mummies they analyzed showed signs of atherosclerosis, suggesting today’s CV hardships might not be the sole product of an unhealthy lifestyle in the 21st century.